Author

C. Woolsey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:non-human primate· 3 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

D. J. Deer· 3 shared J. B. Geisbert· 3 shared K. A. Fenton· 3 shared K. N. Agans· 3 shared T. W. Geisbert· 3 shared V. Borisevich· 3 shared A. N. Prasad· 2 shared N. S. Dobias· 2 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

D. J. Deer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge

C. Woolsey, R. W. Cross, K. N. Agans, V. Borisevich, D. J. Deer, J. B. Geisbert, C. Gerardi, T. E. Lantham, K. A. Fenton, M. Egan, J. H. Eldridge, T. W. Geisbert, D. Matassov

This paper shows a highly attenuated rVSV-based vaccine protects nonhuman primates against lethal Marburg virus challenge when administered up to 1 week before exposure.

bioRxiv · Jan 22, 2022Microbiology

Natural history of nonhuman primates after conjunctival exposure to Ebola virus

R. W. Cross, A. N. Prasad, C. Woolsey, K. N. Agans, V. Borisevich, N. S. Dobias, J. E. Comer, D. J. Deer, J. B. Geisbert, A. Rasmussen, W. I. Lipkin, K. A. Fenton, T. W. Geisbert

This study examines the natural history of Ebola virus infection in nonhuman primates after conjunctival exposure, finding that lower doses result in delayed disease and reduced mortality.

bioRxiv · Dec 29, 2021Microbiology

Use of convalescent serum reduces severity of COVID-19 in nonhuman primates

r. cross, A. N. Prasad, V. Borisevich, C. Woolsey, K. N. Agans, D. J. Deer, N. S. Dobias, J. B. Geisbert, K. A. Fenton, T. W. Geisbert

This study shows that convalescent sera with high neutralizing antibody titers reduce SARS-CoV-2 viral load and disease severity in African green monkeys.

bioRxiv · Oct 14, 2020Microbiology